FIELD: biotechnology.
SUBSTANCE: described is a composition for preventing a disease or condition associated with S. pneumoniae containing glycoconjugates of serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F of S. pneumoniae, constituting a 15, 16, 17, 18, 19 or 20-valent pneumococcal conjugate composition, wherein said glycoconjugate of serotype 33F contains at least 0.6 mmol acetate per mmol capsular polysaccharide of serotype 33F.
EFFECT: invention expands the range of immunogenic compositions for preventing a disease or condition associated with S. Pneumoniae.
57 cl, 16 dwg, 25 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2778704C2 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2687460C2 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULE SACCHARIDE ANTIGENS AND THEIR USE | 2015 |
|
RU2771293C2 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED ANTIGENS OF THE CAPSULAR SACCHARIDE, KITS CONTAINING THESE COMPOSITIONS AND USE THEREOF | 2016 |
|
RU2721128C2 |
| IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCUS VACCINES | 2016 |
|
RU2712622C2 |
| METHODS OF GLYCOGONJUGATION AND COMPOSITION | 2013 |
|
RU2645071C2 |
| METHODS OF GLYCOCONJUGATION AND COMPOSITION | 2013 |
|
RU2724840C2 |
| IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | 2018 |
|
RU2762723C2 |
| GLYCOCONJUGATION PROCESS | 2013 |
|
RU2672053C2 |
| INCREASE IN IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES | 2018 |
|
RU2774891C2 |
